GENEVA, July 2 -- TAKEDA PHARMACEUTICAL COMPANY LIMITED filed a patent application (JP2025/044677) for “LIPID NANO-PARTICLE HAVING A LIGAND TARGETED TO CD7 AND CHIMERIC ANTIGEN RECEPTOR AND USE THEREOF”. With publication no. WO/2026/134350, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 40/11
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....